SCHEDULE: C/M Capital Funds Report 7.2% Stake in Endovia Health
Beneficial Ownership Filing
C/M Capital Master Fund, LP, along with related entities and individuals, has reported beneficial ownership of 7.2% of Endovia Health Sciences, Inc. common stock.
Summary
- This filing is a Schedule 13G, indicating that C/M Capital Master Fund, LP, C/M Capital Partners, LP, Thomas Walsh, and Jonathan Juchno collectively beneficially own 797,592 shares of Endovia Health Sciences, Inc. common stock.
- This ownership stake represents 7.2% of the total outstanding shares.
- The filing date is October 22, 2026, and the event requiring the filing occurred on October 15, 2026.
- C/M Capital Partners, LP acts as the investment manager for C/M Capital Master Fund, LP.
- Thomas Walsh and Jonathan Juchno are managing members of the general partner of C/M Capital Partners, LP.
- Messrs. Walsh and Juchno disclaim beneficial ownership of the shares held by C/M Capital Master Fund.
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update regarding beneficial ownership, with no new financial or strategic information.
Positives
- The filing clarifies the beneficial ownership structure for a significant stake in Endovia Health Sciences, Inc.
- The reporting persons collectively hold a substantial 7.2% interest, indicating significant investor confidence or strategic interest.
Negatives
- The filing does not provide any new financial performance data or strategic updates for Endovia Health Sciences, Inc.
- The disclaimer of beneficial ownership by Messrs. Walsh and Juchno adds a layer of complexity to the control structure.
Risks
- Potential for future changes in beneficial ownership that could impact Endovia Health Sciences, Inc.'s stock stability.
- The nature of the investment (passive vs. active) is not detailed, leaving open questions about the reporting persons' intentions.
Future Outlook
No forward-looking statements or guidance are provided in this filing.
Management Comments
- Messrs. Walsh and Juchno disclaim beneficial ownership of any shares of Common Stock held by C/M Master Fund.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors crossing certain ownership thresholds. This filing indicates a significant passive stake, which is typical for investment funds.
Stakeholder Impact
- Shareholders: The filing provides transparency on a significant beneficial owner, which may influence market perception and trading activity.
- Management: The reporting persons' stake may signal investor interest or potential influence on corporate strategy, though beneficial ownership is disclaimed by individuals.
Next Steps
- Monitor future filings for any changes in beneficial ownership by C/M Capital Master Fund, LP and associated parties.
- Observe any potential strategic actions or communications from the reporting persons regarding their stake in Endovia Health Sciences, Inc.
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Date of outstanding shares reported in Issuer's Definitive Proxy Statement. |
| 2026-10-05 | Date of Issuer's Definitive Proxy Statement filing. |
| 2026-10-15 | Date of Event Which Requires Filing of this Statement. |
| 2026-10-22 | Date of filing of the Schedule 13G and Joint Filing Agreement. |
Keywords
Schedule 13G, Beneficial Ownership, Endovia Health Sciences, C/M Capital Master Fund, C/M Capital Partners, Investment Management, Shareholder Disclosure
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.